<DOC>
	<DOCNO>NCT02245451</DOCNO>
	<brief_summary>The primary objective study characterise effect tipranavir 500 mg ritonavir 200 mg ( TPV/r ; give twice daily ) steady-state pharmacokinetics methadone administer single dose healthy adult volunteer</brief_summary>
	<brief_title>Study Tipranavir Ritonavir Pharmacokinetic Characteristics Methadone Administered Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Male female healthy volunteer age least 18 60 year . Clinically normal medical history . Clinically normal finding physical examination . Clinically normal laboratory value . A Body Mass Index &gt; 18.5 &lt; 30 kg/m2 . Able swallow large capsule without difficulty . Capable comprehend communicate effectively investigator staff provide write informed consent accordance ethic committee regulatory guideline . Willing stay study centre duration study . Willing abstain ingesting substance study may alter plasma study drug level interaction cytochrome P450 system . Willing abstain alcohol 48 hour prior Visit 1 duration study . In addition , Cabernet Sauvignon must ingest within 15 day prior Visit 1 . Willing abstain ingest grapefruit grapefruit juice 15 day Visit 1 duration study . Willing abstain ingest Seville orange , strawberry strawberry extract , garlic supplement , St. John 's Wort , Milk Thistle , methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc ) 72 hour pharmacokinetic sampling day . Willing abstain use tobacco product duration study . Urine drug screen negative illegal nonprescription drug . Negative HIV serology . Negative Hepatitis B surface antigen Hepatitis C Any clinically significant disease . ( A significant disease define disease opinion investigator may either put subject risk participation study disease may influence result study subject 's ability participate study . ) Clinically significant abnormal baseline haematology , blood chemistry urinalysis finding . Serum alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , cholesterol , triglyceride glucose great upper limit normal Visit 1 . Treatment prohibit medication thirty day study study ingestion drug abuse . Treatment investigational drug within 90 day first dose study medication . Inability adhere requirement protocol ( include active substance abuse ) assess investigator . Prior tipranavir use . Ingestion know enzyme alter drug ( phenothiazine , cimetidine , barbiturate , ketoconazole , fluconazole , clarithromycin , rifampin , steroid , herbal medication ) thirty day prior Visit 1 . Ingestion grapefruit , grapefruit juice , Cabernet Sauvignon within fifteen day prior Visit 1 . Ingestion Seville orange , strawberry strawberry extract , garlic supplement , St. John 's Wort , Milk Thistle , methylxanthinecontaining drink food ( coffee , tea , cola , energy drink , chocolate , etc ) within 72 hour pharmacokinetics sample day . Treatment prescription medicine within thirty day prior Visit 1 . History gastrointestinal , hepatic , renal disorder within 60 day prior Visit 1 . Any history alcohol drug abuse . Current use cigarette define great 10 cigarette per day rolling/pipe tobacco equivalent . Blood plasma donation within 90 day prior Visit 1 Subjects seat systolic blood pressure either &lt; 100 mm Hg &gt; 150 mm Hg ; rest heart rate either &lt; 50 beats/min &gt; 100 beats/min . Subjects history illness allergy , opinion investigator , might confound result study pose additional risk administer tipranavir , ritonavir methadone subject . Subjects acute illness within two week prior Visit 1 . Subjects currently take overthecounter drug within fourteen day prior Visit 1 currently take prescription drug . Hypersensitivity tipranavir , ritonavir , methadone . Female subject reproductive potential pregnant , breastfeeding , positive serum BHCG Visit 1 2 , use barrier contraceptive method least three month prior Study Day 1 willing use reliable method doublebarrier contraception ( diaphragm spermicidal cream/jelly condoms spermicidal foam ) study thirty day completion termination study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>